These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

223 related articles for article (PubMed ID: 19479868)

  • 1. Role of CTA1R7K-COL-DD as a novel therapeutic mucosal tolerance-inducing vector for treatment of collagen-induced arthritis.
    Hasselberg A; Schön K; Tarkowski A; Lycke N
    Arthritis Rheum; 2009 Jun; 60(6):1672-82. PubMed ID: 19479868
    [TBL] [Abstract][Full Text] [Related]  

  • 2. ADP-ribosylation controls the outcome of tolerance or enhanced priming following mucosal immunization.
    Hasselberg A; Ekman L; Yrlid LF; Schön K; Lycke NY
    J Immunol; 2010 Mar; 184(6):2776-84. PubMed ID: 20142362
    [TBL] [Abstract][Full Text] [Related]  

  • 3. ADP-ribosylating bacterial enzymes for the targeted control of mucosal tolerance and immunity.
    Lycke N
    Ann N Y Acad Sci; 2004 Dec; 1029():193-208. PubMed ID: 15681758
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Blockade of the interleukin-21/interleukin-21 receptor pathway ameliorates disease in animal models of rheumatoid arthritis.
    Young DA; Hegen M; Ma HL; Whitters MJ; Albert LM; Lowe L; Senices M; Wu PW; Sibley B; Leathurby Y; Brown TP; Nickerson-Nutter C; Keith JC; Collins M
    Arthritis Rheum; 2007 Apr; 56(4):1152-63. PubMed ID: 17393408
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Induction of IL-10-producing CD4+CD25+ T cells in animal model of collagen-induced arthritis by oral administration of type II collagen.
    Min SY; Hwang SY; Park KS; Lee JS; Lee KE; Kim KW; Jung YO; Koh HJ; Do JH; Kim H; Kim HY
    Arthritis Res Ther; 2004; 6(3):R213-9. PubMed ID: 15142267
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Important role of interleukin-3 in the early phase of collagen-induced arthritis.
    Brühl H; Cihak J; Niedermeier M; Denzel A; Rodriguez Gomez M; Talke Y; Goebel N; Plachý J; Stangassinger M; Mack M
    Arthritis Rheum; 2009 May; 60(5):1352-61. PubMed ID: 19404955
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Superior molecularly altered influenza virus hemagglutinin peptide 308-317 inhibits collagen-induced arthritis by inducing CD4+ Treg cell expansion.
    Sun J; Li R; Guo J; Jia Y; Sun X; Liu Y; Li Y; Huang F; Lu L; Li Z
    Arthritis Rheum; 2012 Jul; 64(7):2158-68. PubMed ID: 22231228
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Amelioration of collagen-induced arthritis and suppression of interferon-gamma, interleukin-12, and tumor necrosis factor alpha production by interferon-beta gene therapy.
    Triantaphyllopoulos KA; Williams RO; Tailor H; Chernajovsky Y
    Arthritis Rheum; 1999 Jan; 42(1):90-9. PubMed ID: 9920019
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characterization of a peptide analog of a determinant of type II collagen that suppresses collagen-induced arthritis.
    Myers LK; Tang B; Rosloniec EF; Stuart JM; Chiang TM; Kang AH
    J Immunol; 1998 Oct; 161(7):3589-95. PubMed ID: 9759881
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Suppression of the onset and progression of collagen-induced arthritis by chebulagic acid screened from a natural product library.
    Lee SI; Hyun PM; Kim SH; Kim KS; Lee SK; Kim BS; Maeng PJ; Lim JS
    Arthritis Rheum; 2005 Jan; 52(1):345-53. PubMed ID: 15641090
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Gamma/delta T cells are the predominant source of interleukin-17 in affected joints in collagen-induced arthritis, but not in rheumatoid arthritis.
    Ito Y; Usui T; Kobayashi S; Iguchi-Hashimoto M; Ito H; Yoshitomi H; Nakamura T; Shimizu M; Kawabata D; Yukawa N; Hashimoto M; Sakaguchi N; Sakaguchi S; Yoshifuji H; Nojima T; Ohmura K; Fujii T; Mimori T
    Arthritis Rheum; 2009 Aug; 60(8):2294-303. PubMed ID: 19644886
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Oral administration of type-II collagen suppresses IL-17-associated RANKL expression of CD4+ T cells in collagen-induced arthritis.
    Ju JH; Cho ML; Jhun JY; Park MJ; Oh HJ; Min SY; Cho YG; Hwang SY; Kwok SK; Seo SH; Yoon CH; Park SH; Kim HY
    Immunol Lett; 2008 Apr; 117(1):16-25. PubMed ID: 18242716
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Importance of dose of type II collagen in suppression of collagen-induced arthritis by nasal tolerance.
    Derry CJ; Harper N; Davies DH; Murphy JJ; Staines NA
    Arthritis Rheum; 2001 Aug; 44(8):1917-27. PubMed ID: 11508445
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Amelioration of collagen-induced arthritis in DBA/1J mice by recombinant TSG-6, a tumor necrosis factor/interleukin-1-inducible protein.
    Mindrescu C; Thorbecke GJ; Klein MJ; Vilcek J; Wisniewski HG
    Arthritis Rheum; 2000 Dec; 43(12):2668-77. PubMed ID: 11145024
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immune modulation of collagen-induced arthritis by intranasal cytokine gene delivery: a model for the therapy of rheumatoid arthritis.
    Woods AM; Thompson SJ; Wooley PH; Panayi G; Klavinskis LS
    Arthritis Rheum; 2005 Dec; 52(12):3761-71. PubMed ID: 16329091
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effectiveness of the soluble form of the interleukin-1 receptor accessory protein as an inhibitor of interleukin-1 in collagen-induced arthritis.
    Smeets RL; van de Loo FA; Joosten LA; Arntz OJ; Bennink MB; Loesberg WA; Dmitriev IP; Curiel DT; Martin MU; van den Berg WB
    Arthritis Rheum; 2003 Oct; 48(10):2949-58. PubMed ID: 14558102
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibition of adjuvant-induced arthritis by interleukin-10-driven regulatory cells induced via nasal administration of a peptide analog of an arthritis-related heat-shock protein 60 T cell epitope.
    Prakken BJ; Roord S; van Kooten PJ; Wagenaar JP; van Eden W; Albani S; Wauben MH
    Arthritis Rheum; 2002 Jul; 46(7):1937-46. PubMed ID: 12124879
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Interferon-gamma regulates susceptibility to collagen-induced arthritis through suppression of interleukin-17.
    Chu CQ; Swart D; Alcorn D; Tocker J; Elkon KB
    Arthritis Rheum; 2007 Apr; 56(4):1145-51. PubMed ID: 17393396
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Interleukin-6 blockade suppresses autoimmune arthritis in mice by the inhibition of inflammatory Th17 responses.
    Fujimoto M; Serada S; Mihara M; Uchiyama Y; Yoshida H; Koike N; Ohsugi Y; Nishikawa T; Ripley B; Kimura A; Kishimoto T; Naka T
    Arthritis Rheum; 2008 Dec; 58(12):3710-9. PubMed ID: 19035481
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Differential activities of immunogenic collagen type II peptides in the induction of nasal tolerance to collagen-induced arthritis.
    Chu CQ; Londei M
    J Autoimmun; 1999 Feb; 12(1):35-42. PubMed ID: 10028020
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.